Research develops framework to compare lab, AI, and simulation data

The successful and safe delivery of therapeutics relies on understanding how easily drugs can pass through biological barriers which protect cells.

Amicus stock jumps after resolution of Galafold patent litigation against Teva

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

October 18, 2024

Bluebird and Vertex’s sickle cell gene therapies to kick off new Medicaid access model

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

December 5, 2024

Dating app Grindr hires Tom Daschle’s firm to lobby on HIV prevention, IVF

WASHINGTON — LGBTQ+ dating app Grindr is tapping into the Washington lobbying world amid legislative battles over reproductive health care access. The “Global Gayborhood” has

July 29, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.